Yakira Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-72,590
Closed -$2.17M 225
2025
Q3
$2.17M Sell
72,590
-2,528
-3% -$84.4K 0.76% 37
2025
Q2
$2.23M Sell
75,118
-5,995
-7% -$173K 0.76% 42
2025
Q1
$2.48M Buy
81,113
+10,000
+14% +$337K 0.94% 39
2024
Q4
$2.82M Buy
71,113
+36,113
+103% +$1.4M 1.02% 34
2024
Q3
$1.36M Buy
+35,000
New +$1.42M 0.49% 56

Other funds holding SRDX

Yakira Capital Management's SRDX Position: Q4 2025 in Review

Yakira Capital Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 72,590 shares — an estimated $2.17M sold.

Yakira Capital Management first reported a position in SRDX in Q3 2024 and held it in 5 quarters. The position peaked at $2.82M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Yakira Capital Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Yakira Capital Management sold 72,590 Surmodics shares in Q4 2025, an estimated $2.17M.
  • Yakira Capital Management first reported a position in Surmodics in Q3 2024 and held it in 5 quarters.
  • Yakira Capital Management's Surmodics position peaked at $2.82M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Yakira Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.